Exacerbated by COVID-19 and exemplified by the 45 million Americans with a mental illness, mental health care in the U.S. is insufficient. In recent years, medical professionals have turned to natural medicine for an answer - and they might have found it in psilocybin, the psychoactive substance found in magic mushrooms. Designated as “breakthrough therapy” by the FDA, psilocybin therapy has the potential to reinvent the paradigm for treating psychiatric disorders like addiction, PTSD and depression. Listen to experts in all things mushroom and psychiatry examine the potential of psilocybin mushrooms in revolutionizing mental healthcare. They will discuss ongoing clinical trials, recent medical discoveries and how the fungi may be part of the solution to America’s mental health crisis.
Other Resources / Information
- Learn about psilocybin therapy and how it may be beneficial for many psychiatric and behavioral disorders by looking at data from clinical trials.
- Dispel misconceptions about magic mushrooms and discover recent advancements in psilocybin research.
- Examine the problems with America’s healthcare system and current treatment options for mental illness.
- Alan Davis, PhD, Adjunct Assistant Professor, John Hopkins University
- Rachel Yehuda, Professor of Psychiatry and Neuroscience, Mount Sinai School of Medicine
- Dr. Michael Hart, Plant-Based Medical Expert & Founder, Readytogo Clinic
- Ronan Levy, Founder & Executive Chairman, Field Trip Health
Alanna Zavoico, Creative Content Coordinator, Mattio Communications
SXSW reserves the right to restrict access to or availability of comments related to PanelPicker proposals that it considers objectionable.